Prof. Dr. Tobias Dreischulte
Professor of Clinical Health Services Research, Deputy Director of the Institute
LMU Hospital
Institute for General Medicine
City Center Campus
Nußbaumstraße 5, 80336 Munich
089 4400-55447
089 4400-53768
CV and publications Prof. Dr. Tobias Dreischulte, MSc PhD
Professional stations:
- since 02/2019
Professor of Clinical Health Services Research (W2), Institute of General Medicine, LMU Klinikum, Munich
- 2014 - 2019
Lead for Pharmacy Research and Development/Honorary Senior Lecturer, NHS Tayside/Department of Population Health Sciences, University of Dundee
- 2009 - 2014
Clinical Research fellow, NHS Tayside/Department of Population Health Sciences, University of Dundee, Dundee, UK
- 2006 - 2012
Research fellow (external), Strathclyde Institute for Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK
- 2005 - 2008
Hospital pharmacist, Asklepios Kliniken Hamburg
- 2001 - 2003
Dispensing pharmacist
Qualification:
- 2013
MSc (with distinction) in Pharmacovigilance and Pharmacoepidemiology, Eu2P consortium
- 2012
PhD in Clinical Pharmacy, Strathclyde Institute for Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK
- 2005
MSc (with distinction) in Clinical Pharmacy, Strathclyde Institute for Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK
- 2001
License to practice as a pharmacist
Memberships:
- European Society of Clinical Pharmacy (ESCP)
- Royal Pharmaceutical Society of Great Britain (RPSGB)
- German Pharmaceutical Society (DPhG)
- German Network for Evidence-based Medicine (DNEbM)
Publications:
Brisnik V, Rottenkolber M, Vukas J, Schechner M, Lukaschek K, Jung-Sievers C, et al. Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards. BMC Med. 2024;22(1):378.
Brisnik V, Vukas J, Jung-Sievers C, Lukaschek K, Alexander GC, Thiem U, et al. Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method. BMC Med. 2024;22(1):193.
Hauff J, Rottenkolber M, Oehler P, Fischer S, Gensichen J, Drey M, et al. Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control study. Ageing. 2023;52(6).
Dreischulte T, Donnan PT, Grant A, Hapca A, Guthrie B. Safer prescribing: A trial of incentives, informatics and education. New England Journal of Medicine 2016;17;374(11):1053-64
Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney International 2015;15:101.
Further publications: PubMed - NCBI
